P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi et al., Binding of Hepatitis C Virus to CD81, Science, vol.282, issue.5390, pp.938-941, 1998.
DOI : 10.1126/science.282.5390.938

V. Agnello, G. Abel, M. Elfahal, G. B. Knight, and Q. X. Zhang, Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor, Proceedings of the National Academy of Sciences, vol.74, issue.6, pp.12766-12771, 1999.
DOI : 10.1016/0092-8674(93)90726-7

D. Calvo, D. Gomez-coronado, M. A. Lasuncion, and M. A. Vega, CLA-1 Is an 85-kD Plasma Membrane Glycoprotein That Acts as a High-Affinity Receptor for Both Native (HDL, LDL, and VLDL) and Modified (OxLDL and AcLDL) Lipoproteins, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.17, issue.11, pp.2341-2349, 1997.
DOI : 10.1161/01.ATV.17.11.2341

B. Bartosch and F. L. Cosset, Cell entry of hepatitis C virus, Virology, vol.348, issue.1, pp.1-12, 2006.
DOI : 10.1016/j.virol.2005.12.027
URL : https://hal.archives-ouvertes.fr/hal-00105453

B. Bartosch, J. Dubuisson, and F. L. Cosset, Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003.
DOI : 10.1093/emboj/21.12.2893
URL : https://hal.archives-ouvertes.fr/inserm-00133783

M. Hsu, J. Zhang, M. Flint, C. Logvinoff, C. Cheng-mayer et al., Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles, Proceedings of the National Academy of Sciences, vol.93, issue.26, pp.7271-7276, 2003.
DOI : 10.1073/pnas.93.26.15394

T. Wakita, T. Pietschmann, T. Kato, T. Date, M. Miyamoto et al., Production of infectious hepatitis C virus in tissue culture from a cloned viral genome, Nature Medicine, vol.37, issue.7, pp.791-796, 2005.
DOI : 10.1002/jmv.10297

J. Zhong, P. Gastaminza, G. Cheng, S. Kapadia, T. Kato et al., Robust hepatitis C virus infection in vitro, Proceedings of the National Academy of Sciences, vol.22, issue.8, pp.9294-9299, 2005.
DOI : 10.1016/j.tibtech.2004.06.002

D. G. Bowen and C. M. Walker, Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, vol.38, issue.7053, pp.946-952, 2005.
DOI : 10.1128/JVI.78.3.1575-1581.2004

Y. K. Shimizu, H. Igarashi, T. Kiyohara, T. Cabezon, P. Farci et al., A Hyperimmune Serum against a Synthetic Peptide Corresponding to the Hypervariable Region 1 of Hepatitis C Virus Can Prevent Viral Infection in Cell Cultures, Virology, vol.223, issue.2, pp.409-412, 1996.
DOI : 10.1006/viro.1996.0497

K. Ishii, D. Rosa, Y. Watanabe, T. Katayama, H. Harada et al., High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C, Hepatology, vol.104, issue.4, pp.1117-1120, 1998.
DOI : 10.1002/hep.510280429

J. R. Orland, T. L. Wright, C. , and S. , Acute hepatitis C, Hepatology, vol.33, issue.2, pp.321-327, 2001.
DOI : 10.1053/jhep.2001.22112

D. Lavillette, Y. Morice, G. Germanidis, P. Donot, A. Soulier et al., Human Serum Facilitates Hepatitis C Virus Infection, and Neutralizing Responses Inversely Correlate with Viral Replication Kinetics at the Acute Phase of Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.10, pp.6023-6034, 2005.
DOI : 10.1128/JVI.79.10.6023-6034.2005

B. Bartosch, G. Verney, M. Dreux, P. Donot, Y. Morice et al., An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies, Journal of Virology, vol.79, issue.13, pp.8217-8229, 2005.
DOI : 10.1128/JVI.79.13.8217-8229.2005
URL : https://hal.archives-ouvertes.fr/hal-00313682

B. Bartosch, J. Bukh, J. C. Meunier, C. Granier, R. E. Engle et al., In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes, Proceedings of the National Academy of Sciences, vol.289, issue.5487, pp.14199-14204, 2003.
DOI : 10.1126/science.289.5487.2003a

D. Lavillette, A. W. Tarr, C. Voisset, P. Donot, B. Bartosch et al., Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus, Hepatology, vol.82, issue.2, pp.265-274, 2005.
DOI : 10.1002/hep.20542

C. Logvinoff, M. E. Major, D. Oldach, S. Heyward, A. Talal et al., Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.180, issue.4, pp.10149-10154, 2004.
DOI : 10.1086/314973
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC454180

J. C. Meunier, R. E. Engle, K. Faulk, M. Zhao, B. Bartosch et al., Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1, Proceedings of the National Academy of Sciences, vol.280, issue.9, pp.4560-4565, 2005.
DOI : 10.1074/jbc.M411600200

T. Kanto, N. Hayashi, T. Takehara, H. Hagiwara, E. Mita et al., Density analysis of hepatitis C virus particle population in the circulation of infected hosts: implications for virus neutralization or persistence, Journal of Hepatology, vol.22, issue.4, pp.440-448, 1995.
DOI : 10.1016/0168-8278(95)80107-3

S. U. Nielsen, M. F. Bassendine, A. D. Burt, C. Martin, W. Pumeechockchai et al., Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients, Journal of Virology, vol.80, issue.5, pp.2418-2428, 2006.
DOI : 10.1128/JVI.80.5.2418-2428.2006

A. M. Prince, T. Huima-byron, T. S. Parker, and D. M. Levine, Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins, Journal of Viral Hepatitis, vol.68, issue.1, pp.11-17, 1996.
DOI : 10.1126/science.1279801

P. Farci, A. Shimoda, A. Coiana, G. Diaz, G. Peddis et al., The Outcome of Acute Hepatitis C Predicted by the Evolution of the Viral Quasispecies, Science, vol.288, issue.5464, pp.339-344, 2000.
DOI : 10.1126/science.288.5464.339

Z. Y. Keck, T. K. Li, J. Xia, B. Bartosch, F. L. Cosset et al., Analysis of a Highly Flexible Conformational Immunogenic Domain A in Hepatitis C Virus E2, Journal of Virology, vol.79, issue.21, pp.13199-13208, 2005.
DOI : 10.1128/JVI.79.21.13199-13208.2005
URL : https://hal.archives-ouvertes.fr/hal-00105483

A. Owsianka, A. W. Tarr, V. S. Juttla, D. Lavillette, B. Bartosch et al., Monoclonal Antibody AP33 Defines a Broadly Neutralizing Epitope on the Hepatitis C Virus E2 Envelope Glycoprotein, Journal of Virology, vol.79, issue.17, pp.11095-11104, 2005.
DOI : 10.1128/JVI.79.17.11095-11104.2005

D. J. Schofield, B. Bartosch, Y. K. Shimizu, T. Allander, A. J. Alter et al., Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity, Hepatology, vol.78, issue.7959, pp.1055-1062, 2005.
DOI : 10.1002/hep.20906

B. Bartosch, A. Vitelli, C. Granier, C. Goujon, J. Dubuisson et al., Cell Entry of Hepatitis C Virus Requires a Set of Co-receptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor, Journal of Biological Chemistry, vol.278, issue.43, pp.41624-41630, 2003.
DOI : 10.1074/jbc.M305289200

V. Lohmann, S. Hoffmann, U. Herian, F. Penin, and R. Bartenschlager, Viral and Cellular Determinants of Hepatitis C Virus RNA Replication in Cell Culture, Journal of Virology, vol.77, issue.5, pp.3007-3019, 2003.
DOI : 10.1128/JVI.77.5.3007-3019.2003
URL : https://hal.archives-ouvertes.fr/hal-00313699

T. J. Nieland, A. Chroni, M. L. Fitzgerald, Z. Maliga, V. I. Zannis et al., Cross-inhibition of SR-BI- and ABCA1-mediated cholesterol transport by the small molecules BLT-4 and glyburide, The Journal of Lipid Research, vol.45, issue.7, pp.1256-1265, 2004.
DOI : 10.1194/jlr.M300358-JLR200

A. Owsianka, R. F. Clayton, L. D. Loomis-price, J. A. Mckeating, and A. H. Patel, Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2, Journal of General Virology, vol.82, issue.8, pp.1877-1883, 2001.
DOI : 10.1099/0022-1317-82-8-1877

A. Op-de-beeck, C. Voisset, B. Bartosch, Y. Ciczora, L. Cocquerel et al., Characterization of Functional Hepatitis C Virus Envelope Glycoproteins, Journal of Virology, vol.78, issue.6, pp.2994-3002, 2004.
DOI : 10.1128/JVI.78.6.2994-3002.2004

D. Lavillette, B. Boson, S. Russell, and F. Cosset, Activation of Membrane Fusion by Murine Leukemia Viruses Is Controlled in cis or in trans by Interactions between the Receptor-Binding Domain and a Conserved Disulfide Loop of the Carboxy Terminus of the Surface Glycoprotein, Journal of Virology, vol.75, issue.8, pp.3685-3695, 2001.
DOI : 10.1128/JVI.75.8.3685-3695.2001

S. Ricard-blum, S. Bernocco, B. Font, C. Moali, D. Eichenberger et al., Interaction Properties of the Procollagen C-proteinase Enhancer Protein Shed Light on the Mechanism of Stimulation of BMP-1, Journal of Biological Chemistry, vol.277, issue.37, pp.33864-33869, 2002.
DOI : 10.1074/jbc.M205018200
URL : https://hal.archives-ouvertes.fr/hal-00313822

C. Voisset, N. Callens, E. Blanchard, A. Op-de-beeck, J. Dubuisson et al., High Density Lipoproteins Facilitate Hepatitis C Virus Entry through the Scavenger Receptor Class B Type I, Journal of Biological Chemistry, vol.280, issue.9, pp.7793-7799, 2005.
DOI : 10.1074/jbc.M411600200
URL : https://hal.archives-ouvertes.fr/hal-00105456

M. Krieger, Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems, Journal of Clinical Investigation, vol.108, issue.6, pp.793-797, 2001.
DOI : 10.1172/JCI14011

Z. Y. Keck, V. M. Sung, S. Perkins, J. Rowe, S. Paul et al., Human Monoclonal Antibody to Hepatitis C Virus E1 Glycoprotein That Blocks Virus Attachment and Viral Infectivity, Journal of Virology, vol.78, issue.13, pp.7257-7263, 2004.
DOI : 10.1128/JVI.78.13.7257-7263.2004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC421663

D. Bradley, K. Mccaustland, K. Krawczynski, J. Spelbring, C. Humphrey et al., Hepatitis C virus: Buoyant density if the factor VIII-derived isolate in sucrose, Journal of Medical Virology, vol.65, issue.3, pp.206-208, 1991.
DOI : 10.1002/jmv.1890340315

M. Monazahian, S. Kippenberger, A. Muller, H. Seitz, I. Bohme et al., Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus, Medical Microbiology and Immunology, vol.188, issue.4, pp.177-184, 2000.
DOI : 10.1007/s004300000032

P. Andre, F. Komurian-pradel, S. Deforges, M. Perret, J. L. Berland et al., Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles, Journal of Virology, vol.76, issue.14, pp.6919-6928, 2002.
DOI : 10.1128/JVI.76.14.6919-6928.2002

P. Roingeard, C. Hourioux, E. Blanchard, D. Brand, and M. Ait-goughoulte, Hepatitis C virus ultrastructure and morphogenesis, Biology of the Cell, vol.96, issue.2, pp.103-108, 2004.
DOI : 10.1016/j.biolcel.2003.11.006

M. Triyatni, B. Saunier, P. Maruvada, A. R. Davis, L. Ulianich et al., Interaction of Hepatitis C Virus-Like Particles and Cells: a Model System for Studying Viral Binding and Entry, Journal of Virology, vol.76, issue.18, pp.9335-9344, 2002.
DOI : 10.1128/JVI.76.18.9335-9344.2002

H. E. Drummer, A. Maerz, P. , and P. , Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins, FEBS Letters, vol.75, issue.2-3, pp.385-390, 2003.
DOI : 10.1016/S0014-5793(03)00635-5

A. H. Patel, J. Wood, F. Penin, J. Dubuisson, and J. A. Mckeating, Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: analysis of regions critical for glycoprotein aggregation and CD81 binding, Journal of General Virology, vol.81, issue.12, pp.2873-2883, 2000.
DOI : 10.1099/0022-1317-81-12-2873
URL : https://hal.archives-ouvertes.fr/hal-00313709

D. R. Burton, Antibodies, viruses and vaccines, Nature Reviews Immunology, vol.17, issue.9, pp.706-713, 2002.
DOI : 10.1038/nri891

E. G. Cormier, F. Tsamis, F. Kajumo, R. J. Durso, J. P. Gardner et al., CD81 is an entry coreceptor for hepatitis C virus, Proceedings of the National Academy of Sciences, vol.214, issue.2, pp.7270-7274, 2004.
DOI : 10.1111/j.1574-6968.2002.tb11338.x

J. A. Mckeating, L. Q. Zhang, C. Logvinoff, M. Flint, J. Zhang et al., Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner, Journal of Virology, vol.78, issue.16, pp.8496-8505, 2004.
DOI : 10.1128/JVI.78.16.8496-8505.2004

J. Zhang, G. Randall, A. Higginbottom, P. Monk, C. M. Rice et al., CD81 Is Required for Hepatitis C Virus Glycoprotein-Mediated Viral Infection, Journal of Virology, vol.78, issue.3, pp.1448-1455, 2004.
DOI : 10.1128/JVI.78.3.1448-1455.2004
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC321402

H. Barth, R. Cerino, M. Arcuri, M. Hoffmann, P. Schurmann et al., Scavenger Receptor Class B Type I and Hepatitis C Virus Infection of Primary Tupaia Hepatocytes, Journal of Virology, vol.79, issue.9, pp.5774-5785, 2005.
DOI : 10.1128/JVI.79.9.5774-5785.2005

T. A. Pagler, S. Rhode, A. Neuhofer, H. Laggner, W. Strobl et al., SR-BI-mediated High Density Lipoprotein (HDL) Endocytosis Leads to HDL Resecretion Facilitating Cholesterol Efflux, Journal of Biological Chemistry, vol.281, issue.16, pp.11193-11204, 2006.
DOI : 10.1074/jbc.M510261200

D. Lavillette, B. Bartosch, D. Nourrisson, G. Verney, F. L. Cosset et al., Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes, Journal of Biological Chemistry, vol.281, issue.7, pp.3909-3917, 2006.
DOI : 10.1074/jbc.M509747200
URL : https://hal.archives-ouvertes.fr/hal-00313675

Y. Peng, W. Akmentin, M. A. Connelly, S. Lund-katz, M. C. Phillips et al., Scavenger Receptor BI (SR-BI) Clustered on Microvillar Extensions Suggests that This Plasma Membrane Domain Is a Way Station for Cholesterol Trafficking between Cells and High-Density Lipoprotein, Molecular Biology of the Cell, vol.15, issue.1, pp.384-396, 2004.
DOI : 10.1091/mbc.E03-06-0445

F. Zimetti, G. K. Weibel, M. Duong, R. , and G. H. , Measurement of cholesterol bidirectional flux between cells and lipoproteins, The Journal of Lipid Research, vol.47, issue.3, pp.605-613, 2006.
DOI : 10.1194/jlr.M500466-JLR200

S. Charrin, S. Manie, C. Thiele, M. Billard, D. Gerlier et al., A physical and functional link between cholesterol and tetraspanins, European Journal of Immunology, vol.33, issue.9, pp.2479-2489, 2003.
DOI : 10.1002/eji.200323884
URL : https://hal.archives-ouvertes.fr/hal-00112786

F. Penin, C. Combet, G. Germanidis, P. O. Frainais, G. Deleage et al., Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment, Journal of Virology, vol.75, issue.12, pp.5703-5710, 2001.
DOI : 10.1128/JVI.75.12.5703-5710.2001
URL : https://hal.archives-ouvertes.fr/hal-00313708

S. Zucchelli, R. Roccasecca, A. Meola, B. B. Ercole, R. Tafi et al., Mimotopes of the hepatitis C virus hypervariable region 1, but not the natural sequences, induce cross-reactive antibody response by genetic immunization, Hepatology, vol.33, issue.3, pp.692-703, 2001.
DOI : 10.1053/jhep.2001.22175

R. F. Garry and S. Dash, Proteomics computational analyses suggest that hepatitis C virus E1 and pestivirus E2 envelope glycoproteins are truncated class II fusion proteins, Virology, vol.307, issue.2, pp.255-265, 2003.
DOI : 10.1016/S0042-6822(02)00065-X
URL : http://doi.org/10.1016/s0042-6822(02)00065-x

K. G. Hadlock, R. E. Lanford, S. Perkins, J. Rowe, Q. Yang et al., Human Monoclonal Antibodies That Inhibit Binding of Hepatitis C Virus E2 Protein to CD81 and Recognize Conserved Conformational Epitopes, Journal of Virology, vol.74, issue.22, pp.10407-10416, 2000.
DOI : 10.1128/JVI.74.22.10407-10416.2000

T. H. Heo, J. H. Chang, J. W. Lee, S. K. Foung, J. Dubuisson et al., Incomplete Humoral Immunity against Hepatitis C Virus Is Linked with Distinct Recognition of Putative Multiple Receptors by E2 Envelope Glycoprotein, The Journal of Immunology, vol.173, issue.1, pp.446-455, 2004.
DOI : 10.4049/jimmunol.173.1.446